Barrett's Esophagus with High-Grade Dysplasia
- 1 July 1996
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Annals of Surgery
- Vol. 224 (1), 66-71
- https://doi.org/10.1097/00000658-199607000-00010
Abstract
The authors review the results and outcomes of esophagectomy (prophylactic esophagectomy) for patients with Barrett's esophagus and high-grade epithelial dysplasia (HGD). The role of prophylactic esophagectomy for Barrett's esophagus with HGD is controversial, with some authors recommending surgery and others favoring endoscopic surveillance until biopsy diagnosis of carcinoma is made. Between 1982 and 1994, 30 consecutive patients with HGD underwent esophagectomy and had the pre- and postoperative pathology reviewed at our institution. The medical records were reviewed to determine patient characteristics, preoperative endoscopic data, surgical approach, operative morbidity and mortality, length of hospitalization, and treatment outcome. Patients were divided into two groups based on whether invasive adenocarcinoma was found in the resection specimen (group 1) or not (group 2). The duration of reflux symptoms was 22 +/- 14 years for group 1 and 9 +/- 11 years for group 2 (p = 0.05). There was one operative death (3.3%) and six complications (20%). In 13 patients (43%, group 1), invasive adenocarcinoma was found in the resected esophagus. The American Joint Committee on Cancer stage for these patients was stage I (8 patients), stage II (2 patients), and stage III (3 patients). One stage I patient died of adenocarcinoma (72 months) in an incompletely excised HGD segment. Other stage I and II patients are alive without adenocarcinoma with an 18-and 63-month mean follow-up, respectively. Outcome for stage III patients was one operative death, one noncancer death (6 months), and one patient with metastatic adenocarcinoma (26 months). For group 2 (57%), there were no adenocarcinoma deaths (40 months). High-grade epithelial dysplasia is an indication for esophagectomy because of the prevalence of occult adenocarcinoma (43%). Esophagectomy can be performed safely, and survival in patients with completely resected Barrett's esophagus and early-stage adenocarcinoma is excellent.Keywords
This publication has 10 references indexed in Scilit:
- Endosonography in the evaluation of patients with Barrett's esophagus and high-grade dysplasiaGastrointestinal Endoscopy, 1994
- An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagusGastroenterology, 1993
- Barrett's esophagus with high-grade dysplasia: An indication for esophagectomy?The Annals of Thoracic Surgery, 1992
- The neoplastic potential of columnar‐lined (Barrett's) esophagusWorld Journal of Surgery, 1992
- Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus.Gut, 1991
- High-grade dysplasia in the columnar-lined esophagusThe American Journal of Surgery, 1991
- Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesionsGastroenterology, 1988
- The Relationship Between Columnar Epithelial Dysplasia and Invasive Adenocarcinoma Arising in Barrett’s EsophagusAmerican Journal of Clinical Pathology, 1987
- Adenocarcinoma in Barrett's esophagus after elimination of gastroesophageal reflux.1984
- Adenocarcinoma in Barrett's esophagus after elimination of gastroesophageal refluxGastroenterology, 1984